Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has given approval to India-based Aurobindo Pharma to manufacture and market Ramipril capsules USP 1.25mg, 2.5mg, 5mg and 10mg.
Subscribe to our email newsletter
Aurobindo Pharma‘s Ramipril capsules USP 1.25mg, 2.5mg, 5mg and 10mg are generic equivalent to King Pharmaceuticals’ Altace capsules 1.25mg, 2.5mg, 5mg and 10mg.
Altace capsules are indicated as a treatment for hypertension which falls under cardiovascular therapeutic segment.
Altace is a angiotensin-converting enzyme (ACE) inhibitor that works by relaxing blood vessels.